BLACKSTONE / TPG acquires HOLOGIC (2026)

Deal facts

Buyer: BLACKSTONE / TPG
Target: HOLOGIC
Deal value: Not disclosed
Announced: 22 January 2026
Status: In review
Sector: Healthcare
Country: Not stated
Consideration: Not stated

Sources

EU_DG_COMP

What we know

Weekly digest

Join Exit Mode Insider

Ten deal briefs a week, founder commentary, and the patterns worth paying attention to.

Join Exit Mode Insider, £12/mo

Deal timeline

1 update

15 Feb 2026CMA invitation to comment
BLACKSTONE / TPG / HOLOGIC
BLACKSTONE / TPG / HOLOGIC
EU DG COMP

OpinionExit Mode editorial

We see a significant shift in the healthcare sector as Blackstone and TPG jointly move to acquire Hologic. This is not a standard private equity buyout but a consortium deal, which signals that the buyers are pooling capital and expertise to tackle a large, complex target. The transaction remains in review, a status that immediately raises the spectre of rigorous regulatory scrutiny. For a deal of this magnitude involving medical diagnostics and breast health technologies, competition authorities in both the UK and the EU will likely examine market concentration with a fine-tooth comb. The CMA and the European Commission have shown little patience for consolidation that could reduce choice or inflate prices for health services.

The involvement of two major firms suggests a strategy focused on operational scale rather than a simple financial flip. They are likely looking to restructure the business, perhaps by separating distinct business units or integrating new technologies, which often triggers specific change-of-control covenants in existing debt agreements. You, the SME founder, should note that even if you are not selling a billion-pound company today, the mechanics here are relevant. Large buyers often demand extensive escrow arrangements or earn-out contingencies when regulatory approval is uncertain, as the deal cannot close until clearance is granted. This creates a period of limbo where the target company must operate under strict standstill provisions, limiting its ability to make strategic moves or hire key staff.

The absence of a disclosed value in the announcement is typical for deals still under review, but the sector focus is clear. Healthcare assets are prized for their defensive cash flows, yet they carry heavy compliance burdens. A consortium structure can dilute risk for individual investors but often complicates decision-making during the clearance phase. We think this deal highlights a growing trend where private capital seeks to dominate niche healthcare markets, but the path to completion is rarely smooth. The regulatory hurdles are not mere formalities; they are substantive barriers that can alter the deal economics or kill the transaction entirely if competition concerns are not addressed early.

Your immediate action this week should be to review your own customer concentration and supplier contracts to identify any clauses that could be triggered by a change of control. Many founders overlook these provisions until a buyer is at the table, only to find that their key suppliers or lenders have veto rights or demand immediate repayment. Map out these dependencies now so you are not caught off guard when a serious offer arrives.

Editorial opinion. Not financial or legal advice.

Explore

Browse adjacent archives

Jump from this deal into the sector, buyer, deal type, and year views that carry the strongest contextual signal.

More Healthcare deals More 2026 deals More pe acquisition deals More from BLACKSTONE / TPG All M&A deals

Similar deals

Other Healthcare M&A activity tracked by Exit Mode.

16 April 2026Firm intentionHealthcare

CCP PAW 2 LIMITED to acquire Animalcare Group plc

CCP PAW 2 LIMITED has agreed to acquire Animalcare Group plc in a private equity acquisition valued at 235.2 million GBP. The transaction, announced on 16 April 2026, in…

Buyer: CCP PAW 2 LIMITED
Target: Animalcare Group plc
Deal value: GBP 235,200,000
Deal type: pe acquisition

Read deal Healthcare deals pe acquisition deals United Kingdom deals

3 September 2025In reviewHealthcare

BAIN CAPITAL / KOHLBERG to acquire PCI PHARMA GROUP

BAIN CAPITAL / KOHLBERG and PCI PHARMA GROUP entered the Exit Mode archive.

Buyer: BAIN CAPITAL / KOHLBERG
Target: PCI PHARMA GROUP
Deal value: Not disclosed
Deal type: pe acquisition

Read deal Healthcare deals pe acquisition deals In review deals

9 July 2025In reviewHealthcare

KKR to acquire KARO HEALTHCARE

KKR has agreed to acquire KARO HEALTHCARE in a private equity acquisition. The transaction was announced on 9 July 2025. The target operates within the NaceV2Sector_N_72…

Buyer: KKR
Target: KARO HEALTHCARE
Deal value: Not disclosed
Deal type: pe acquisition

Read deal Healthcare deals pe acquisition deals In review deals

11 May 2025In reviewHealthcare

HELLMAN & FRIEDMAN / CVC to acquire MEHILÄINEN

Hellman & Friedman and CVC have agreed to acquire Mehiläinen, a Finnish healthcare provider, in a private equity acquisition announced on 11 May 2025. The transaction in…

Buyer: HELLMAN & FRIEDMAN / CVC
Target: MEHILÄINEN
Deal value: Not disclosed
Deal type: pe acquisition

Read deal Healthcare deals pe acquisition deals Finland deals

4 May 2025In reviewHealthcare

MADISON DEARBORN PARTNERS / THOMA BRAVO to acquire NEXTGEN HEALTHCARE

MADISON DEARBORN PARTNERS and THOMA BRAVO have agreed to acquire NEXTGEN HEALTHCARE in a private equity acquisition. The transaction was announced on 4 May 2025. The tar…

Buyer: MADISON DEARBORN PARTNERS / THOMA BRAVO
Target: NEXTGEN HEALTHCARE
Deal value: Not disclosed
Deal type: pe acquisition

Read deal Healthcare deals pe acquisition deals In review deals

Buyer history

BLACKSTONE / TPG

See every published Exit Mode archive entry where this buyer appears.

View buyer profile

Methodology

How this page is built

Layer 1 facts come from source documents, Layer 2 turns those facts into a readable narrative, and Layer 3 only appears where the editorial team flags a founder-relevant deal.

Back to the archive

BLACKSTONE / TPG to acquire HOLOGIC

Deal facts

Join Exit Mode Insider

Deal timeline

Browse adjacent archives

Similar deals

CCP PAW 2 LIMITED to acquire Animalcare Group plc

BAIN CAPITAL / KOHLBERG to acquire PCI PHARMA GROUP

KKR to acquire KARO HEALTHCARE

HELLMAN & FRIEDMAN / CVC to acquire MEHILÄINEN

MADISON DEARBORN PARTNERS / THOMA BRAVO to acquire NEXTGEN HEALTHCARE

BLACKSTONE / TPG

How this page is built